Updates

Showing

T 0192/22 - Is a first medical use claim a magic bullet?

The EIP team was pleased to receive the BoA Decision on T 0197/22 earlier this month, providing the reasons for revocation of Translate Bio’s EP 3318248 B1 at the oral proceedings held in March, where we represented one of the Opponents. The p...

To Injunct Or Not To Injunct?

Judge Asked To Grant A 9/10 Day Interim Injunction to Protect Bayer’s Anticoagulant Rivaroxaban Ahead of Main Judgment Pharmaceutical company, Bayer found success in its application seeking an interim injunction, lasting just 9-10 days, to prot...

Partner Promotions

EIP promotes quartet to its international partnership EIP is proud to announce an expansion of our international partnership with the promotion of four from our team: Alex Morgan, Ben Willows, Isabelle Schaller, and Sebastian Fuchs. This strategic en...

AI and Big Data in Agritech

First published by Process Engineering - February 2024 The world’s population stands above 8 billion in 2024 and is still growing. That growth may be slowing down but nonetheless there may be another 2 billion mouths to feed in the next 50 year...

Technology and Climate change

Key points The transition to green energy may reduce the cost of energy as renewable energy becomes cheaper than fossil fuels for most applications. Cheaper energy will support future technology. The environmental impact of technologies such as a...

Abbott v Dexcom [2024] EWHC 36 (Pat)

Abbott v Dexcom [2024] EWHC 36 (Pat) Background The first UK battle held in the wide-ranging (both in terms of number of patents and geographical area) patent fight between Abbott and Dexcom has ended in a stalemate. Mr Justice Mellor has found two...